A citation-based method for searching scientific literature

C Mignot, A Gelot, B Bessières, F Daffos, M Voyer, F Menez, C Fallet Bianco, S Odent, D Le Duff, P Loget, P Fargier, J Costil, P Josset, J Roume, M T Vanier, I Maire, T Billette de Villemeur. Am J Med Genet A 2003
Times Cited: 67







List of co-cited articles
481 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum.
Michael J Eblan, Ozlem Goker-Alpan, Ellen Sidransky. Fetal Pediatr Pathol 2005
35
48

Type 2 Gaucher disease: 15 new cases and review of the literature.
Cyril Mignot, Diana Doummar, Irène Maire, Thierry Billette De Villemeur. Brain Dev 2006
81
25

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
D L Stone, N Tayebi, E Orvisky, B Stubblefield, V Madike, E Sidransky. Hum Mutat 2000
150
19

Gaucher disease: complexity in a "simple" disorder.
Ellen Sidransky. Mol Genet Metab 2004
264
19

Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.
Eduard Orvisky, Joseph K Park, Mary E LaMarca, Edward I Ginns, Brian M Martin, Nahid Tayebi, Ellen Sidransky. Mol Genet Metab 2002
128
17

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.
Ozlem Goker-Alpan, Raphael Schiffmann, Joseph K Park, Barbara K Stubblefield, Nahid Tayebi, Ellen Sidransky. J Pediatr 2003
92
17

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
V Koprivica, D L Stone, J K Park, M Callahan, A Frisch, I J Cohen, N Tayebi, E Sidransky. Am J Hum Genet 2000
219
16

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
N W Barton, R O Brady, J M Dambrosia, A M Di Bisceglie, S H Doppelt, S C Hill, H J Mankin, G J Murray, R I Parker, C E Argoff. N Engl J Med 1991
992
16

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
J Charrow, H C Andersson, P Kaplan, E H Kolodny, P Mistry, G Pastores, B E Rosenbloom, C R Scott, R S Wappner, N J Weinreb,[...]. Arch Intern Med 2000
332
16

Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?
D L Stone, O P van Diggelen, J B de Klerk, J L Gaillard, M F Niermeijer, R Willemsen, N Tayebi, E Sidransky. Eur J Hum Genet 1999
34
29


Neuropathology provides clues to the pathophysiology of Gaucher disease.
Kondi Wong, Ellen Sidransky, Ajay Verma, Tonghui Mixon, Glenn D Sandberg, Laura K Wakefield, Alan Morrison, Alicia Lwin, Carlos Colegial, John M Allman,[...]. Mol Genet Metab 2004
318
14

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
Paige Kaplan, Hans C Andersson, Katherine A Kacena, John D Yee. Arch Pediatr Adolesc Med 2006
124
14

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
Kathleen S Hruska, Mary E LaMarca, C Ronald Scott, Ellen Sidransky. Hum Mutat 2008
402
14

Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.
N Gupta, I M Oppenheim, E F Kauvar, N Tayebi, E Sidransky. Blood Cells Mol Dis 2011
52
19


Type 2 Gaucher disease: the collodion baby phenotype revisited.
D L Stone, W F Carey, J Christodoulou, D Sillence, P Nelson, M Callahan, N Tayebi, E Sidransky. Arch Dis Child Fetal Neonatal Ed 2000
56
16

Collodion babies with Gaucher's disease.
K Lui, C Commens, R Choong, R Jaworski. Arch Dis Child 1988
62
14

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
C E Hollak, S van Weely, M H van Oers, J M Aerts. J Clin Invest 1994
653
13

Neonatal cholestasis and infantile Gaucher disease: a case report.
C Barbier, L Devisme, D Dobbelaere, O Noizet, B Nelken, F Gottrand. Acta Paediatr 2002
11
81

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
E Sidransky, M A Nalls, J O Aasly, J Aharon-Peretz, G Annesi, E R Barbosa, A Bar-Shira, D Berg, J Bras, A Brice,[...]. N Engl J Med 2009
13

Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
N Tayebi, K J Reissner, E K Lau, B K Stubblefield, A C Klineburgess, B M Martin, E Sidransky. Pediatr Res 1998
49
16

The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.
E Sidransky, N Tayebi, B K Stubblefield, W Eliason, A Klineburgess, G P Pizzolato, J N Cox, J Porta, A Bottani, C D DeLozier-Blanchet. J Med Genet 1996
36
22

Type 2 gaucher disease: an expanding phenotype.
N Tayebi, D L Stone, E Sidransky. Mol Genet Metab 1999
31
25

New perspectives in type 2 Gaucher disease.
E Sidransky. Adv Pediatr 1997
30
26

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Joseph R Mazzulli, You-Hai Xu, Ying Sun, Adam L Knight, Pamela J McLean, Guy A Caldwell, Ellen Sidransky, Gregory A Grabowski, Dimitri Krainc. Cell 2011
866
11

Neuronopathic forms of Gaucher's disease.
A Erikson, B Bembi, R Schiffmann. Baillieres Clin Haematol 1997
65
10


Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
V L Tybulewicz, M L Tremblay, M E LaMarca, R Willemsen, B K Stubblefield, S Winfield, B Zablocka, E Sidransky, B M Martin, S P Huang. Nature 1992
244
10

Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease.
E Sidransky, M Fartasch, R E Lee, L A Metlay, S Abella, A Zimran, W Gao, P M Elias, E I Ginns, W M Holleran. Pediatr Res 1996
65
10

Hydrops fetalis: lysosomal storage disorders in extremis.
D L Stone, E Sidransky. Adv Pediatr 1999
51
13

Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.
Joseph K Park, Eduard Orvisky, Nahid Tayebi, Christine Kaneski, Mary E Lamarca, Barbara K Stubblefield, Brian M Martin, Raphael Schiffmann, Ellen Sidransky. Pediatr Res 2003
68
10


Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.
Nahid Tayebi, Barbara K Stubblefield, Joseph K Park, Eduard Orvisky, Jamie M Walker, Mary E LaMarca, Ellen Sidransky. Am J Hum Genet 2003
83
10

Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
Amparo Chabás, Laura Gort, Anna Díaz-Font, Magdalena Montfort, Raül Santamaría, Manuel Cidrás, Daniel Grinberg, Lluïsa Vilageliu. Blood Cells Mol Dis 2005
24
29

Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.
Leonie A Boven, Marjan van Meurs, Rolf G Boot, Atul Mehta, Louis Boon, Johannes M Aerts, Jon D Laman. Am J Clin Pathol 2004
193
10

Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.
Pramod K Mistry, Sandra Sirrs, Alicia Chan, Mark R Pritzker, Thomas P Duffy, Marie E Grace, David P Meeker, Martin E Goldman. Mol Genet Metab 2002
119
10

Randomized, controlled trial of miglustat in Gaucher's disease type 3.
Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, Catherine DeVile, Elin H Davies, Larry Abel, Ivo N van Schaik, William Benko, Margaret Timmons, Markus Ries,[...]. Ann Neurol 2008
145
10


The clinical management of Type 2 Gaucher disease.
Karin Weiss, Ashley Gonzalez, Grisel Lopez, Leah Pedoeim, Catherine Groden, Ellen Sidransky. Mol Genet Metab 2015
52
13

Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation.
E Orvisky, E Sidransky, C E McKinney, M E Lamarca, R Samimi, D Krasnewich, B M Martin, E I Ginns. Pediatr Res 2000
76
8

The human glucocerebrosidase gene and pseudogene: structure and evolution.
M Horowitz, S Wilder, Z Horowitz, O Reiner, T Gelbart, E Beutler. Genomics 1989
342
8

Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.
N Tayebi, S R Cushner, W Kleijer, E K Lau, P J Damschroder-Williams, B K Stubblefield, J Den Hollander, E Sidransky. Am J Med Genet 1997
37
16

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.
W M Holleran, E I Ginns, G K Menon, J U Grundmann, M Fartasch, C E McKinney, P M Elias, E Sidransky. J Clin Invest 1994
218
8

Fine structure of central nervous system in early infantile Gaucher's disease.
M Adachi, B J Wallace, L Schneck, B W Volk. Arch Pathol 1967
56
10

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.
G Altarescu, S Hill, E Wiggs, N Jeffries, C Kreps, C C Parker, R O Brady, N W Barton, R Schiffmann. J Pediatr 2001
122
8

Management of neuronopathic Gaucher disease: a European consensus.
A Vellodi, B Bembi, T B de Villemeur, T Collin-Histed, A Erikson, E Mengel, A Rolfs, A Tylki-Szymanska. J Inherit Metab Dis 2001
90
8

Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease.
Patrick B Deegan, Mary Teresa Moran, Ian McFarlane, J Paul Schofield, Rolf G Boot, Johannes M F G Aerts, Timothy M Cox. Blood Cells Mol Dis 2005
91
8

Skeletal aspects of Gaucher disease: a review.
R J Wenstrup, M Roca-Espiau, N J Weinreb, B Bembi. Br J Radiol 2002
154
8

Prevalence of lysosomal storage disorders.
P J Meikle, J J Hopwood, A E Clague, W F Carey. JAMA 1999
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.